Private Equity

Petrichor Closes Oversubscribed Fund I At $410M

by posted 7months ago 90 views
NEW YORK, November 3, 2020-- Petrichor Healthcare Capital Management (“Petrichor”), a private equity firm that makes structured investments in the healthcare sector, today announced the final close of Petrichor Opportunities Fund I, LP which was oversubscribed with $410 million in capital commitments. Founded by Tadd Wessel, Managing Partner, Petrichor has a strong track record of identifying and supporting world-class management teams and their companies in the life sciences and healthcare sectors. To date, Petrichor has invested in five companies including LumiraDx, Cryoport (Nasdaq: CYRX), CorneaGen, Persivia, and ClearPoint Neuro (Nasdaq: CLPT).